CARsgen Therapeutics Holdings Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
CARsgen Therapeutics Holdings has a total shareholder equity of CN¥1.5B and total debt of CN¥129.1M, which brings its debt-to-equity ratio to 8.6%. Its total assets and total liabilities are CN¥2.1B and CN¥605.2M respectively.
Anahtar bilgiler
8.6%
Borç/özkaynak oranı
CN¥129.12m
Borç
| Faiz karşılama oranı | n/a |
| Nakit | CN¥1.65b |
| Eşitlik | CN¥1.50b |
| Toplam yükümlülükler | CN¥605.18m |
| Toplam varlıklar | CN¥2.10b |
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 2171's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥183.7M).
Uzun Vadeli Yükümlülükler: 2171's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥421.5M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 2171 has more cash than its total debt.
Borcun Azaltılması: Insufficient data to determine if 2171's debt to equity ratio has reduced over the past 5 years.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: 2171 has sufficient cash runway for more than a year based on its current free cash flow.
Tahmini Nakit Akışı: 2171 has sufficient cash runway for 2.2 years if free cash flow continues to reduce at historical rates of 9.1% each year.